Detailed instructions for fezolinetant and interpretation of medication precautions

Fezolinetant is an oral small molecule selective neurokinin -1 receptor antagonist (NK3 receptor antagonist). It is mainly used to treat hot flashes in menopausal women. As an innovative drug, Fezonatant relieves the common symptoms of hot flashes and night sweats in menopause by regulating the hypothalamic temperature control center, thereby improving the quality of life of patients. The following content will introduce in detail the key points of the instructions and medication precautions for Fezonatant to help patients use it scientifically and rationally.

1. Indications and mechanism of action of filazonatant

Fezonatant is approved for the treatment of moderate to severe hot flashes due to menopause. After menopause, the level of estrogen in the body decreases, which affects the hypothalamus' regulation of body temperature, causing the neurokinin system to be abnormally active, causing vasodilation and abnormal sweating. Fezonatan can effectively reduce the symptoms of hot flashes by selectively blocking NK3 receptors, inhibiting abnormal neurokinin signaling, and regulating the body temperature center.

2. Medication dosage and administration method

According to clinical studies and labeling recommendations, fezonatant is usually taken as an oral dosage form, once daily, with the dosage ranging from 45mg to 90mg. Patients should take it strictly on time as directed by the doctor, and should not increase or decrease the dose at will. The drug can be taken with food or on an empty stomach, but it is recommended to take the drug at a fixed time to ensure stable blood concentration. If you have not finished taking the medicine, you should not stop taking it on your own. You should inform your doctor for professional guidance.

3. Adverse reactions and monitoring requirements

Clinical trials have shown that fezonatant is well tolerated, but some patients may experience mild to moderate side effects, including headache, fatigue, nausea, insomnia, and joint pain. In addition, a small number of patients may develop liver function abnormalities, so it is recommended to monitor liver function indicators before starting treatment and regularly during treatment. If you find significant increases in liver enzymes or signs of liver damage such as jaundice or skin itching, you should seek medical attention immediately and consider suspending medication.

4. Precautions and contraindications for taking medication

1.Taboo groups

Fezonastat is contraindicated in pregnant and breastfeeding women because its safety has not been established. People who are allergic to drug ingredients are also prohibited from using it. Patients with severe hepatic impairment should avoid taking it.

2.Drug interactions

Fizolinant is mainly metabolized by the liver, especially the CYP3A4 enzyme system, so it should be avoided with strong CYP3A4Use inhibitors or inducers at the same time to prevent abnormal increases or decreases in drug concentration, affecting efficacy and safety.

3.Regular follow-up visits

During the treatment period, patients should return to the clinic on time for liver function, routine blood tests and other tests. If you experience severe symptoms such as persistent abdominal pain, jaundice, mental abnormalities, etc., you need to contact your doctor promptly.

4.Lifestyle adjustments

In order to cooperate with the efficacy of the drug, patients should maintain healthy living habits, avoid smoking and alcohol abuse, exercise appropriately, and maintain a good sleep environment and routine to help relieve menopausal symptoms.

As the first batch of approved NK3 receptor antagonists, filzonitant provides a new treatment option for menopausal patients with hot flashes. It is convenient to take orally, has a unique mechanism of action and has mild side effects, making it an effective alternative to traditional hormone replacement therapy. However, patients still need to strictly abide by medical instructions during use, regularly monitor liver function, pay attention to potential drug interactions, and provide timely feedback on adverse reactions. Through the scientific and reasonable use of filazonatan, menopausal women can effectively relieve hot flash symptoms and significantly improve their quality of life.

Reference materials:https://www.drugs.com/